IGF-1 promotes β-amyloid production by a secretase-independent mechanism

Biochemical and Biophysical Research Communications

Volumn 380, Issue 1, 2009, Pages 111-114

  Araki, Wataru ^a   Kume, Hideaki ^a   Oda, Akiko ^a,b   Tamaoka, Akira ^a,b   Kametani, Fuyuki ^c  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Amyloid; Alzheimer's disease; IGF 1; Neuroblastoma; Phosphorylation

Indexed keywords

ALANINE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE INHIBITOR; SECRETASE; SOMATOMEDIN C;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; CELL LINE, TUMOR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY;

EID: 59649083403     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.01.044     Document Type: Article

References (34)

1. Selkoe D.J. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease. J. Clin. Invest. 110 (2002) 1375-1381
2. Haass C. Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J. 23 (2004) 483-488
3. Venters H.D., Broussard S.R., Zhou J.H., Bluthé R.M., Freund G.G., Johnson R.W., Dantzer R., and Kelley K.W. Tumor necrosis factor(alpha) and insulin-like growth factor-I in the brain: is the whole greater than the sum of its parts?. J. Neuroimmunol. 119 (2001) 151-165
4. Davila D., Piriz J., Trejo J.L., Nunez A., and Torres-Aleman I. Insulin and insulin-like growth factor I signalling in neurons. Front. Biosci. 12 (2007) 3194-3202
5. Zheng W.H., Kar S., Doré S., and Quirion R. Insulin-like growth factor-1 (IGF-1): a neuroprotective trophic factor acting via the Akt kinase pathway. J. Neural Transm. Suppl. 60 (2000) 261-272
6. Gasparini L., and Xu H. Potential roles of insulin and IGF-1 in Alzheimer's disease. Ternds Neurosci. 26 (2003) 404-406
7. Carro E., and Torres-Aleman I. The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. Eur. J. Pharmacol. 490 (2004) 127-133
8. Gasparini L., Gouras G.K., Wang R., Gross R.S., Beal M.F., Greengard P., and Xu H. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J. Neurosci. 21 (2001) 2561-2570
9. Rivera E.J., Goldin A., Fulmer N., Tavares R., Wands J.R., and de la Monte S.M. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J. Alzheimer's Dis. 8 (2005) 247-268
10. Alvarez A., Cacabelos R., Sanpedro C., García-Fantini M., and Aleixandre M. Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol. Aging 28 (2007) 533-536
11. Tei E., Yamamoto H., Watanabe T., Miyazaki A., Nakadate T., Kato N., and Mimura M. Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer's disease. Growth Horm. IGF Res. 18 (2008) 47-54
12. Kume H., Maruyama K., and Kametani F. Gamma-secretase can cleave amyloid precursor protein fragments independent of alpha- and beta-secretase pre-cutting. Int. J. Mol. Med. 13 (2004) 121-125
13. Murayama K.S., Kametani F., Saito S., Kume H., Akiyama H., and Araki W. Reticulons RTN3 and RTN4-B/C interact with BACE1 and inhibit its ability to produce amyloid beta-protein. Eur. J. Neurosci. 24 (2006) 1237-1244
14. Takeda K., Araki W., and Tabira T. Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2. Eur. J. Neurosci. 19 (2004) 258-264
15. Kametani F., Tanaka K., Ishii T., Ikeda S., Kennedy H.E., and Allsop D. Secretory form of Alzheimer amyloid precursor protein 695 in human brain lacks beta/A4 amyloid immunoreactivity. Biochem. Biophys. Res. Commun. 191 (1993) 392-398
16. Dovey H.F., John V., Anderson J.P., Chen L.Z., de Saint Andrieu P., Fang L.Y., Freedman S.B., Folmer B., Goldbach E., Holsztynska E.J., Hu K.L., Johnson-Wood K.L., Kennedy S.L., Kholodenko D., Knops J.E., Latimer L.H., Lee M., Liao Z., Lieberburg I.M., Motter R.N., Mutter L.C., Nietz J., Quinn K.P., Sacchi K.L., Seubert P.A., Shopp G.M., Thorsett E.D., Tung J.S., Wu J., Yang S., Yin C.T., Schenk D.B., May P.C., Altstiel L.D., Bender M.H., Boggs L.N., Britton T.C., Clemens J.C., Czilli D.L., Dieckman-McGinty D.K., Droste J.J., Fuson K.S., Gitter B.D., Hyslop P.A., Johnstone E.M., Li W.Y., Little S.P., Mabry T.E., Miller F.D., and Audia J.E. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J. Neurochem. 76 (2001) 173-181
17. Li Y.M., Lai M.T., Xu M., Huang Q., DiMuzio-Mower J., Sardana M.K., Shi X.P., Yin K.C., Shafer J.A., and Gardell S.J. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc. Natl. Acad. Sci. USA 97 (2000) 6138-6143
18. Araki W., Yuasa K., Takeda S., Takeda K., Shirotani K., Takahashi K., and Tabira T. Pro-apoptotic effect of presenilin 2 (PS2) overexpression is associated with down-regulation of Bcl-2 in cultured neurons. J. Neurochem. 79 (2001) 1161-1168
19. Kim B., van Golen C.M., and Feldman E.L. Insulin-like growth factor-I signaling in human neuroblastoma cells. Oncogene 23 (2004) 130-141
20. Takeda K., Araki W., Akiyama H., and Tabira T. Amino-truncated amyloid beta-peptide (Abeta5-40/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer's disease brain. FASEB J. 18 (2004) 1755-1757
21. Flood F., Murphy S., Cowburn R.F., Lannfelt L., Walker B., and Johnston J.A. Proteasome-mediated effects on amyloid precursor protein processing at the gamma-secretase site. Biochem. J. 385 (2005) 545-550
22. Vingtdeux V., Hamdane M., Gompel M., Bégard S., Drobecq H., Ghestem A., Grosjean M.E., Kostanjevecki V., Grognet P., Vanmechelen E., Buée L., Delacourte A., and Sergeant N. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism. Neurobiol. Dis. 20 (2005) 625-637
23. Costantini C., Scrable H., and Puglielli L. An aging pathway controls the TrkA to p75NTR receptor switch and amyloid beta-peptide generation. EMBO J. 35 (2006) 1997-2006
24. Vincent A.M., and Feldman E.L. Control of cell survival by IGF signaling pathways. Growth Horm. IGF Res. 12 (2002) 193-197
25. Adlerz L., Holback S., Multhaup G., and Iverfeldt K. IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways. J. Biol. Chem. 282 (2007) 10203-10209
26. Iijima K., Ando K., Takeda S., Satoh Y., Seki T., Itohara S., Greengard P., Kirino Y., Nairn A.C., and Suzuki T. Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5. J. Neurochem. 75 (2000) 1085-1091
27. Lee M.S., Kao S.C., Lemere C.A., Xia W., Tseng H.C., Zhou Y., Neve R., Ahlijanian M.K., and Tsai L.H. APP processing is regulated by cytoplasmic phosphorylation. J. Cell Biol. 163 (2003) 83-95
28. Liu F., Su Y., Li B., Zhou Y., Ryder J., Gonzalez-DeWhitt P., May P.C., and Ni B. Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5. FEBS Lett. 547 (2003) 193-196
29. Standen C.L., Brownlees J., Grierson A.J., Kesavapany S., Lau K.F., McLoughlin D.M., and Miller C.C. Phosphorylation of thr(668) in the cytoplasmic domain of the Alzheimer's disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3). J. Neurochem. 76 (2001) 316-320
30. Muresan Z., and Muresan V. c-Jun NH2-terminal kinase-interacting protein-3 facilitates phosphorylation and controls localization of amyloid-beta precursor protein. J. Neurosci. 25 (2005) 3741-3751
31. Ryoo S.R., Cho H.J., Lee H.W., Jeong H.K., Radnaabazar C., Kim Y.S., Kim M.J., Son M.Y., Seo H., Chung S.H., and Song W.J. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease. J. Neurochem. 104 (2008) 1333-1344
32. Carro E., Trejo J.L., Gomez-Isla T., LeRoith D., and Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat. Med. 8 (2002) 1390-1397
33. Carro E., Trejo J.L., Gerber A., Loetscher H., Torrado J., Metzger F., and Torres-Aleman I. Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis. Neurobiol. Aging 27 (2006) 1250-1257
34. Sevigny J.J., Ryan J.M., van Dyck C.H., Peng Y., Lines C.R., and Nessly M.L. MK-677 protocol 30 study group, growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial. Neurology 71 (2008) 1702-1708